Lisata Therapeutics Inc.

NASDAQ: LSTA · Real-Time Price · USD
2.52
-0.04 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
2.53
0.40%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lisata Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
16.21M 22.59M 32.15M 24.65M
Short-Term Investments
15.04M 27.94M 37.07M 70.32M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
160K 24K 528K 764K
Receivables
900K 1M n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.43M n/a 2.65M n/a
Total Current Assets
34.58M 53.92M 71.88M 96.18M
Property-Plant & Equipment
72K 483K 296K 62K
Goodwill & Intangibles
192K 263K 334K n/a
Total Long-Term Assets
424K 770K 1.16M 826K
Total Assets
35M 54.69M 73.03M 97.01M
Account Payables
1.28M 2.42M 2.65M 1.93M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
137K 168K 180K 229K
Other Current Liabilities
-137K -168K 782K -229K
Total Current Liabilities
5.61M 6.59M 6.38M 4.52M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
72K 73K 22K n/a
Total Long-Term Liabilities
72K 210K 327K 485K
Total Liabilities
5.68M 6.8M 6.71M 5.01M
Total Debt
137K 305K 485K 714K
Common Stock
8K 8K 8K 60K
Retained Earnings
-548.07M -528.08M -507.24M -453.02M
Comprehensive Income
-81K -42K -29K -70K
Shareholders Equity
29.57M 48.15M 66.58M 92.25M
Total Investments
15.04M 27.94M 37.07M 70.32M